Reports - Infectious Disease Diagnostics Market
Biotechnology and Life SciencesInfectious Disease Diagnostics Market
Infectious Disease Diagnostics Market Size, Share & Growth Forecast by 2035 by Product (Reagents, Kits, and Consumables, Instruments, Software & Services), by Type of Testing (Laboratory Testing, POC Testing), by Technology (Immunodiagnostics, Clinical Microbiology , PCR , INAAT ), by Disease Type (COVID-19, HIV , HAIs , Hepatitis ), by End User (Diagnostic Laboratories, Hospitals & Clinics , Academic Research Institutes , Other End Users), by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Infectious Disease Diagnostics Market - Segment Analysis
1. Overview
2. Global Infectious Disease Diagnostics Market, 2021 - 2035 (USD Million)
3. Global Infectious Disease Diagnostics Market - by Product
3.1. By Reagents, Kits, and Consumables
3.2. By Instruments
3.3. By Software & Services
4. Global Infectious Disease Diagnostics Market - by Type of Testing
4.1. By Laboratory Testing
4.2. By POC Testing
5. Global Infectious Disease Diagnostics Market - by Technology
5.1. By Immunodiagnostics
5.2. By Clinical Microbiology
5.3. By PCR
5.4. By INAAT
5.5. By DNA Sequencing & NGS
5.6. By DNA Microarrays
5.7. By Other technologies
6. Global Infectious Disease Diagnostics Market - by Disease Type
6.1. By COVID-19
6.2. By HIV
6.3. By HAIs
6.4. By Hepatitis
6.5. By CT/NG
6.6. By HPV
6.7. By TB
6.8. By Influenza
6.9. By Other Infectious Diseases
7. Global Infectious Disease Diagnostics Market - by End User
7.1. By Diagnostic Laboratories
7.2. By Hospitals & Clinics
7.3. By Academic Research Institutes
7.4. By Other End Users
8. Global Infectious Disease Diagnostics Market - by region
8.1. North America
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
9. Market comparative analysis
Chapter 4 North America Infectious Disease Diagnostics Market - Segment Analysis
1. Overview
2. North America Infectious Disease Diagnostics Market, 2021 - 2035 (USD Million)
3. North America Infectious Disease Diagnostics Market - by Product
3.1. By Reagents, Kits, and Consumables
3.2. By Instruments
3.3. By Software & Services
4. North America Infectious Disease Diagnostics Market - by Type of Testing
4.1. By Laboratory Testing
4.2. By POC Testing
5. North America Infectious Disease Diagnostics Market - by Technology
5.1. By Immunodiagnostics
5.2. By Clinical Microbiology
5.3. By PCR
5.4. By INAAT
5.5. By DNA Sequencing & NGS
5.6. By DNA Microarrays
5.7. By Other technologies
6. North America Infectious Disease Diagnostics Market - by Disease Type
6.1. By COVID-19
6.2. By HIV
6.3. By HAIs
6.4. By Hepatitis
6.5. By CT/NG
6.6. By HPV
6.7. By TB
6.8. By Influenza
6.9. By Other Infectious Diseases
7. North America Infectious Disease Diagnostics Market - by End User
7.1. By Diagnostic Laboratories
7.2. By Hospitals & Clinics
7.3. By Academic Research Institutes
7.4. By Other End Users
Chapter 5 Europe Infectious Disease Diagnostics Market - Segment Analysis
1. Overview
2. Europe Infectious Disease Diagnostics Market, 2021 - 2035 (USD Million)
3. Europe Infectious Disease Diagnostics Market - by Product
3.1. By Reagents, Kits, and Consumables
3.2. By Instruments
3.3. By Software & Services
4. Europe Infectious Disease Diagnostics Market - by Type of Testing
4.1. By Laboratory Testing
4.2. By POC Testing
5. Europe Infectious Disease Diagnostics Market - by Technology
5.1. By Immunodiagnostics
5.2. By Clinical Microbiology
5.3. By PCR
5.4. By INAAT
5.5. By DNA Sequencing & NGS
5.6. By DNA Microarrays
5.7. By Other technologies
6. Europe Infectious Disease Diagnostics Market - by Disease Type
6.1. By COVID-19
6.2. By HIV
6.3. By HAIs
6.4. By Hepatitis
6.5. By CT/NG
6.6. By HPV
6.7. By TB
6.8. By Influenza
6.9. By Other Infectious Diseases
7. Europe Infectious Disease Diagnostics Market - by End User
7.1. By Diagnostic Laboratories
7.2. By Hospitals & Clinics
7.3. By Academic Research Institutes
7.4. By Other End Users
Chapter 6 Asia Pacific Infectious Disease Diagnostics Market - Segment Analysis
1. Overview
2. Asia Pacific Infectious Disease Diagnostics Market, 2021 - 2035 (USD Million)
3. Asia Pacific Infectious Disease Diagnostics Market - by Product
3.1. By Reagents, Kits, and Consumables
3.2. By Instruments
3.3. By Software & Services
4. Asia Pacific Infectious Disease Diagnostics Market - by Type of Testing
4.1. By Laboratory Testing
4.2. By POC Testing
5. Asia Pacific Infectious Disease Diagnostics Market - by Technology
5.1. By Immunodiagnostics
5.2. By Clinical Microbiology
5.3. By PCR
5.4. By INAAT
5.5. By DNA Sequencing & NGS
5.6. By DNA Microarrays
5.7. By Other technologies
6. Asia Pacific Infectious Disease Diagnostics Market - by Disease Type
6.1. By COVID-19
6.2. By HIV
6.3. By HAIs
6.4. By Hepatitis
6.5. By CT/NG
6.6. By HPV
6.7. By TB
6.8. By Influenza
6.9. By Other Infectious Diseases
7. Asia Pacific Infectious Disease Diagnostics Market - by End User
7.1. By Diagnostic Laboratories
7.2. By Hospitals & Clinics
7.3. By Academic Research Institutes
7.4. By Other End Users
Chapter 7 Latin America Infectious Disease Diagnostics Market - Segment Analysis
1. Overview
2. Latin America Infectious Disease Diagnostics Market, 2021 - 2035 (USD Million)
3. Latin America Infectious Disease Diagnostics Market - by Product
3.1. By Reagents, Kits, and Consumables
3.2. By Instruments
3.3. By Software & Services
4. Latin America Infectious Disease Diagnostics Market - by Type of Testing
4.1. By Laboratory Testing
4.2. By POC Testing
5. Latin America Infectious Disease Diagnostics Market - by Technology
5.1. By Immunodiagnostics
5.2. By Clinical Microbiology
5.3. By PCR
5.4. By INAAT
5.5. By DNA Sequencing & NGS
5.6. By DNA Microarrays
5.7. By Other technologies
6. Latin America Infectious Disease Diagnostics Market - by Disease Type
6.1. By COVID-19
6.2. By HIV
6.3. By HAIs
6.4. By Hepatitis
6.5. By CT/NG
6.6. By HPV
6.7. By TB
6.8. By Influenza
6.9. By Other Infectious Diseases
7. Latin America Infectious Disease Diagnostics Market - by End User
7.1. By Diagnostic Laboratories
7.2. By Hospitals & Clinics
7.3. By Academic Research Institutes
7.4. By Other End Users
Chapter 8 Middle East & Africa Infectious Disease Diagnostics Market - Segment Analysis
1. Overview
2. Middle East & Africa Infectious Disease Diagnostics Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Infectious Disease Diagnostics Market - by Product
3.1. By Reagents, Kits, and Consumables
3.2. By Instruments
3.3. By Software & Services
4. Middle East & Africa Infectious Disease Diagnostics Market - by Type of Testing
4.1. By Laboratory Testing
4.2. By POC Testing
5. Middle East & Africa Infectious Disease Diagnostics Market - by Technology
5.1. By Immunodiagnostics
5.2. By Clinical Microbiology
5.3. By PCR
5.4. By INAAT
5.5. By DNA Sequencing & NGS
5.6. By DNA Microarrays
5.7. By Other technologies
6. Middle East & Africa Infectious Disease Diagnostics Market - by Disease Type
6.1. By COVID-19
6.2. By HIV
6.3. By HAIs
6.4. By Hepatitis
6.5. By CT/NG
6.6. By HPV
6.7. By TB
6.8. By Influenza
6.9. By Other Infectious Diseases
7. Middle East & Africa Infectious Disease Diagnostics Market - by End User
7.1. By Diagnostic Laboratories
7.2. By Hospitals & Clinics
7.3. By Academic Research Institutes
7.4. By Other End Users
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Abbott Laboratories (US)
2. F. Hoffmann-La Roche Ltd(Switzerland)
3. bioMérieux SA (France)
4. Thermo Fisher Scientific Inc. (US)
5. Danaher Corporation (US)
6. Quidel Corporation(US)
7. Hologic Inc. (US)
8. Siemens Healthineers AG (Germany)
9. Becton
10. Dickinson and Company (US)
11. PerkinElmer Inc. (US)
12. QIAGEN (Netherlands)
13. Grifols S.A. (Spain)
14. DiaSorin S.p.A (Italy)
15. Bio-Rad Laboratories Inc. (US)
16. Sysmex Corporation (Japan)
17. Ortho Clinical Diagnostics (US)
18. Luminex Corporation (US)
19. Meridian Bioscience (US)
20. Genetic Signatures (Australia)
21. OraSure Technologies (US)
22. Trinity Biotech Plc. (Ireland)
23. Chembio Diagnostic Systems Inc. (US)
24. Seegene Inc. (South Korea)
25. Co-Diagnostics Inc. (US)
26. ELITechGroup (France)
27. Epitope Diagnostics Inc. (US)
28. Trivitron Healthcare (India)
29. Meril Life Sciences Pvt. Ltd. (India)
30. InBios International Inc. (US)
31. and ABACUS Diagnostica Oy (Finland).
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By